NOVARTIS’ APPEAL DISMISSED BY SC, CANCER PATIENTS GET BIG RELIEF
2013-04-01 23:01 -NEW DELHI : In a major victory for patients fighting for access to medicines, a division bench of the Supreme Court of India comprising Hon’ble Justice Aftab Alam and hon’ble Justice Ranjana Desai, today dismissed Swiss MNC Novartis’ appeal for a patent to Novartis for its anti-cancer medicine, imatinib mesylate (Gleevec).